In 2009, Tom Foti co-founded Aldevron’s Protein Business Unit and currently serves in the role of Vice President / General Management. Aldevron’s Protein Business Unit offers development and manufacturing services to the research, diagnostic and therapeutic markets and is based in Madison, WI.
Tom has been instrumental in developing and launching the CRISPR product line at Aldevron. From off-the-shelf products to custom GMP manufacturing, he and his team has helped clients advance their programs from concept to the clinic. Tom has also been at the forefront of providing Ribonucleoprotien (RNP) services to the research and therapeutic markets. His guidance and foresight have kept Aldevron in a leadership position in the competitive gene and cell therapy markets.
Tom has more than 30 years of biotechnology experience and prior to joining Aldevron, he served in several roles in Merck KGaA’s Bioscience Division (2000-2008), most recently as the Director of its Global Custom Services Business. He started his career in 1992, with Novagen, Inc. serving in scientific, manufacturing and operational roles until 1999. He played college basketball while earning a Bachelor’s of Science in Biotechnology and Microbiology from North Dakota State University. He holds a Master’s in Business Administration from Edgewood College and a Management Leadership Certificate from Massachusetts Institute of Technology.